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Phenolic compound such as resveratrol has been suggested to
prevent cancer and heart diseases because of its anti-oxidant
and anti-inflammatory activities [1]. However, therapeutic ap-
plication of resveratrol is quite limited due to its poor solubility,
low bioavailability, photosensitive and auto-oxidation proper-
ties [2]. The aim of this study was to prepare resveratrol-
loaded emulsions using pectin as an emulsifier.The emulsions
should be stable for up to 7 days, before further manufactur-
ing processes.
Resveratrol-loaded emulsions were prepared by simple ho-
mogenization using Imwitor® 742 as an oil phase (10% w/w).
Resveratrol was dissolved in Imwitor® 742; solubility of
resveratrol in Imwitor® 742 was 9.53 ± 0.52 mg/mL. The influ-
ence of type (i.e., low methoxy pectin (LMP) and high methoxy
pectin (HMP)) and concentration (i.e., 2% and 3% w/w) of pectin
on the droplet size, zeta potential, viscosity, stability (by visu-
ally observed percent creaming and automatic stability analysis)
and morphology of emulsions were examined.The stability of
emulsions after storage at ambient temperature (25 °C) for
7 days and under environmental stress condition (i.e.,
centrifugation test) was compared with the freshly prepared
emulsions (day 0). The microscopic image of emulsions con-
taining HMP (3% w/w) and resveratrol is shown in Fig. 1A.The
emulsion droplet size was increased from 19.34 ± 2.6 μm (day
0) to 26.95 ± 1.76 μm (day 7). From visual observation, emul-
sions containing HMP (3% w/w) and resveratrol did not show
phase separation (100% creaming) after centrifugation test and
7-day stability test. However, the results by automatic stabil-
ity analyzer showed the difference between the emulsions after
centrifugation test and 7-day stability test (Fig. 1B). It could be
concluded that the emulsions containing HMP (3% w/w) and
resveratrol provide themost stable emulsions compared to other
formulations.
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Fig. 1 – (A) Microscopic image and (B) backscattering patterns of emulsions containing HMP (3% w/w) and resveratrol.
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